BSE filing, NSE: CORONA. Summary written from the filing by ALFA Finder's alert engine.
Corona Remedies Ltd: key numbers
- Share price
- ₹2,175.00
- Market cap
- ₹13,302 Cr
- Revenue (annual)
- ₹1,403 Cr
- Net profit (annual)
- ₹185.1 Cr
- P/E (TTM)
- 66.8×Sector 48.7×
- Promoter holding
- 69.00%+0.00% QoQ
- FII holding
- 4.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Corona Remedies Ltd
All →Corona Remedies Q2 FY27 Results: Net Profit ₹60.3 Cr, Up 15.3% YoY
Corona Remedies Ltd reported revenue from operations of ₹441.2 Cr (+22.2% YoY) and net profit of ₹60.3 Cr (+15.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹60.3 Cr · +15.3% YoY
Corona Remedies Business Update
Corona Remedies received GMP Compliance Certification from Brazil's ANVISA for its OSD and Hormone facilities in Ahmedabad. This validates export eligibility to the Brazilian pharmaceutical market.
Corona Remedies Board Meeting Date
Corona Remedies Limited will hold a board meeting on October 30, 2026. The board will consider unaudited financial results for the quarter and half-year ended September 30, 2026.
Corona Remedies Other Announcement
This filing contains quarterly shareholding pattern disclosures for Corona Remedies Ltd. It provides details on share distribution as required by regulatory compliance norms.
Corona Remedies Credit Rating
CARE Ratings has reaffirmed and upgraded the credit ratings assigned to Corona Remedies Limited's bank facilities, as disclosed in the latest regulatory filing.
Corona Remedies Capital Structure Change
Sepia Investments Limited, Sage Investment Trust, and Anchor Partners sold 2,629,880 equity shares of Corona Remedies Limited. This non-promoter stake sale is disclosed under SEBI SAST regulations.
Other results update announcements
All →LCC Projects Results Update
LCC Projects reported Q2 FY27 revenue of Rs 8,857 mn, up 34% year-on-year. Order book stood at Rs 81,466 mn.
Reliance Industries Results Update
Reliance Industries' media release reports Q2 FY27 consolidated revenue of ₹3,62,268 crore and EBITDA of ₹62,409 crore. Profit after tax rose 33.8% year-on-year.
Ratnaveer Precision Engineering Results Update
Ratnaveer Precision reported Q2 FY27 revenue up 35% and PAT up 56% year on year. Its FR-4 CCL project is about 75% complete.
- FR-4 CCL annual production capacity
- 15.84 lakh sheets/year
Qualiance International Results Update
Qualiance International reported H1 FY27 revenue of ₹30.97 Cr and PAT of ₹3.74 Cr, down from ₹38.46 Cr and ₹5.25 Cr a year earlier. Its press release also flags a new facility expected to triple capacity by FY28.
Jio Platforms Results Update
Jio Platforms issued a media release on its Q2 FY27 unaudited results, with gross revenue up 11.3% and EBITDA up 16.6% year-on-year. It also highlights subscriber milestones.
Aarti Industries Results Update
Aarti Industries issued a press release on Q2 and H1 FY27 unaudited results, reporting record quarterly EBITDA and higher volumes. Growth was driven by export demand.
- fuel additives capacity
- 70.0 KTPA